1. Home
  2. APPN vs MANE Comparison

APPN vs MANE Comparison

Compare APPN & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Appian Corporation

APPN

Appian Corporation

HOLD

Current Price

$26.65

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

MANE

Veradermics Incorporated Common Stock

N/A

Current Price

$48.73

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
APPN
MANE
Founded
1999
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
APPN
MANE
Price
$26.65
$48.73
Analyst Decision
Hold
Strong Buy
Analyst Count
6
4
Target Price
$33.83
$78.33
AVG Volume (30 Days)
1.2M
238.3K
Earning Date
05-21-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
101.59
N/A
EPS
0.02
N/A
Revenue
$226,743,000.00
N/A
Revenue This Year
$13.79
N/A
Revenue Next Year
$10.56
N/A
P/E Ratio
$1,348.75
N/A
Revenue Growth
28.29
N/A
52 Week Low
$21.77
$36.26
52 Week High
$46.06
$51.56

Technical Indicators

Market Signals
Indicator
APPN
MANE
Relative Strength Index (RSI) 49.08 68.32
Support Level $21.77 $39.73
Resistance Level $31.83 $51.21
Average True Range (ATR) 1.44 3.86
MACD 0.53 0.23
Stochastic Oscillator 83.56 78.12

Price Performance

Historical Comparison
APPN
MANE

About APPN Appian Corporation

Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its business in the United States.

About MANE Veradermics Incorporated Common Stock

Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.

Share on Social Networks: